頁籤選單縮合
| 題 名 | Therapeutic Drug Monitoring Study on the Switch from Coformulated 600-mg Efavirenz, Tenofovir Disoproxil Fumarate, and Emtricitabine to Coformulated 400-mg Efavirenz, Tenofovir Disoproxil Fumarate, and Lamivudine among HIV-positive Patients with Viral Suppression |
|---|---|
| 作 者 | Huang, Wei-chieh; Huang, Chun-kai; Huang, Sung-hsi; Lin, Shu-wen; Ou, Shyh-tyan; Chen, Yi-ting; Chen, Ya-wen; Chang, Shu-yuan; Liu, Wen-chun; Sun, Hsin-yun; Hung, Chien-ching; | 書刊名 | Journal of Microbiology, Immunology and Infection |
| 卷 期 | 54:5 2021.10[民110.10] |
| 頁 次 | 頁944-951 |
| 分類號 | 418.285 |
| 關鍵詞 | Antiretroviral therapy; Mid-dose plasma concentration; Neuropsychiatric adverse effects; Non-nucleoside reverse transcriptase inhibitor; Switch therapy; |
| 語 文 | 英文(English) |